EHop-016
CAS No. 1380432-32-5
EHop-016( EHop016 | EHop-016 | EHop 016 | EHOP016 )
Catalog No. M11575 CAS No. 1380432-32-5
EHop-016 is a specific Rac GTPase inhibitor with IC50 of 1.1 μM for Rac1 in MDA-MB-435 and MDA-MB-231 cells, equally potent inhibition for Rac3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 36 | In Stock |
|
| 10MG | 60 | In Stock |
|
| 25MG | 116 | In Stock |
|
| 50MG | 203 | In Stock |
|
| 100MG | 317 | In Stock |
|
| 200MG | 466 | In Stock |
|
| 500MG | 746 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEHop-016
-
NoteResearch use only, not for human use.
-
Brief DescriptionEHop-016 is a specific Rac GTPase inhibitor with IC50 of 1.1 μM for Rac1 in MDA-MB-435 and MDA-MB-231 cells, equally potent inhibition for Rac3.
-
DescriptionEHop-016 is a specific Rac GTPase inhibitor with IC50 of 1.1 μM for Rac1 in MDA-MB-435 and MDA-MB-231 cells, equally potent inhibition for Rac3.
-
In VitroWestern Blot Analysis Cell Line:MDA-MB-435 cells Concentration:1 μM, 2 μM, 4 μM, 5 μM, 10 μM Incubation Time:24 hours Result:The activity Rac3 was inhibited by 58%.
-
In VivoAnimal Model:Female athymic nu/nu mice (4-5 weeks old) injected with GFP-MDA-MB-435 cells Dosage:10 mg/kg, 25 mg/kg Administration:Intraperitoneal injection; 3 times a week; for 55 days Result:Significantly reduced mammary fat pad tumor growth, metastasis, and angiogenesis.
-
SynonymsEHop016 | EHop-016 | EHop 016 | EHOP016
-
PathwayCell Cycle/DNA Damage
-
TargetRho
-
RecptorRac1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1380432-32-5
-
Formula Weight430.55
-
Molecular FormulaC25H30N6O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 86 mg/mL (199.74 mM)
-
SMILESCCN1C2=C(C3=C1C=CC=C3)C=C(NC4=NC(NCCCN5CCOCC5)=NC=C4)C=C2
-
Chemical NameN4-(9-ethyl-9H-carbazol-3-yl)-N2-(3-morpholinopropyl)pyrimidine-2,4-diamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Montalvo-Ortiz BL, et al. J Biol Chem. 2012, 287(16), 13228-13238.
molnova catalog
related products
-
CCG-100602
CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells (IC50 :9.8 μM).
-
NS1643
NS1643 is a potent human ether-a-go-go related gene (hERG) KV11.1 channel activator with EC50 of 10.5 μM.
-
1A-116
1A-116 is a specific Rac1 inhibitor.
Cart
sales@molnova.com